Patient characteristics of long-term responders to mogamulizumab: results from the MAVORIC study.

Eur J Cancer

INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; University of Paris Diderot, Sorbonne Paris Cité, Paris, France; Laboratoire d'Immunologie-Histocompatibilité, Hôpital Saint Louis, AP-HP, Paris, France.

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(21)00715-2DOI Listing

Publication Analysis

Top Keywords

patient characteristics
4
characteristics long-term
4
long-term responders
4
responders mogamulizumab
4
mogamulizumab mavoric
4
mavoric study
4
patient
1
long-term
1
responders
1
mogamulizumab
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!